Lensar (LNSR) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Lensar (LNSR) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | 11.06% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -6.18% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 189.50% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -54.61% |
| 10 | Lensar | 66.89 Mn | 55.79 Mn | 6.38 Mn | 377.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 377.31% |
| Dec 31, 2025 | -125.72% |
| Sep 30, 2025 | 6.75% |
| Jun 30, 2025 | 90.19% |
| Mar 31, 2025 | 45.07% |
| Dec 31, 2024 | 97.28% |
| Sep 30, 2024 | -59.82% |
| Jun 30, 2024 | -86.62% |
| Mar 31, 2024 | 23.35% |
| Dec 31, 2023 | -73.81% |
| Sep 30, 2023 | 40.78% |
| Jun 30, 2023 | -50.86% |
| Mar 31, 2023 | 45.23% |
| Dec 31, 2022 | 47.01% |
| Sep 30, 2022 | 42.18% |
| Jun 30, 2022 | -93.10% |
| Mar 31, 2022 | -59.72% |
| Dec 31, 2021 | -190.72% |
| Sep 30, 2021 | 73.72% |
| Jun 30, 2021 | 85.86% |